search
Back to results

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1) (OPAL-Aim 1)

Primary Purpose

HIV/AIDS

Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
HIV-focused mobilization
Multi-disease-focused mobilization
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV/AIDS focused on measuring Drinking venues, Biomedical HIV prevention, Uganda, Kenya

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Participant Inclusion Criteria: adult (≥18 years) patron or worker at a drinking venue within the study community Exclusion Criteria: age <18 years previous participation in the study (may only participate once) inability to consent (including gross inebriation)

Sites / Locations

  • Kenya Medical Research Institute (KEMRI)Recruiting
  • Infectious Diseases Research Collaboration (IDRC)Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Aim 1: HIV-focused mobilization

Aim 1: Multi-disease-focused mobilization

Arm Description

Patrons and workers at drinking venues will be given a recruitment card for free HIV testing at the local clinic.

Patrons and workers at drinking venues will be given a recruitment card for free multi-disease testing at the local clinic, including: diabetes, hypertension, HIV, malaria, TB, pregnancy.

Outcomes

Primary Outcome Measures

Biomedical HIV prevention uptake at 4 weeks
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.

Secondary Outcome Measures

Biomedical HIV prevention uptake at 8 weeks
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.
Biomedical HIV prevention uptake at 12 weeks
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.
HIV testing uptake
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who accept clinic-based HIV testing at the clinic screening visit. HIV testing will be done in accordance with Kenyan and Ugandan national testing algorithms. Uptake will be recorded on study CRFs.
Yield of adults with untreated HIV
The proportion of persons accepting HIV testing who are identified with newly diagnosed HIV or those who are self-reported to have known HIV infection but out of care and off of ART. HIV testing will be done in accordance with Kenyan and Ugandan national testing algorithms. Uptake, test results, HIV status, and current ART use will be recorded on study CRFs.
Yield of adults with heavy alcohol use
Heavy alcohol use is defined as self-reported AUDIT-C score (a standardized, three question survey) of greater than or equal to 4 for men and greater than or equal to 3 for women. These outcomes will be recorded on study CRFs.
Adults with untreated HIV who initiate ART
The proportion of adults with untreated HIV that initiate ART. Current and prior ART use will be self-reported and recoded on study CRFs. New ART prescriptions will be measured through pill dispensing data and MoH registries.

Full Information

First Posted
May 8, 2023
Last Updated
August 9, 2023
Sponsor
University of California, San Francisco
Collaborators
University of California, Berkeley, Makerere University, Infectious Diseases Research Collaboration, Uganda, Kenya Medical Research Institute, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05862857
Brief Title
The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)
Acronym
OPAL-Aim 1
Official Title
Innovative Strategies to Promote Biomedical HIV Prevention Uptake and Retention Among High-risk Adults at Drinking Venues in Kenya and Uganda
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 13, 2023 (Actual)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
May 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
University of California, Berkeley, Makerere University, Infectious Diseases Research Collaboration, Uganda, Kenya Medical Research Institute, National Institute on Alcohol Abuse and Alcoholism (NIAAA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will test innovative interventions to increase uptake and use of biomedical HIV prevention options by engaging women and men at drinking venues in rural Kenya and Uganda in care, while gaining insights into the facilitators, barriers, and cost-effectiveness of these approaches.
Detailed Description
[BACKGROUND] Alcohol use is a common risk factor for both HIV prevention uptake and retention in sub-Saharan Africa (SSA). Interventions that promote biomedical HIV prevention (PrEP and PEP) among persons with heavy alcohol use and their sexual partners are urgently needed. Alcohol-serving drinking venues play an important role as sites of HIV transmission in SSA and are ideal sites to engage women and men at increased risk of HIV in biomedical prevention services. [OVERVIEW] The investigators have developed a mobilization strategy of integrating HIV testing within multi-disease screening to recruit >2,000 people from drinking venues in Kenya and Uganda. The investigators now need to determine whether multi-disease mobilization can promote uptake of HIV prevention for adults at drinking venues in the context of new biomedical prevention options. The project will rigorously test innovative interventions in Kenya and Uganda to increase uptake of biomedical HIV prevention, and assess facilitators, barriers, and cost-effectiveness of these approaches. Specific Aims: Compare the effectiveness of two mobilization strategies to increase uptake of biomedical HIV prevention among adults at drinking venues. Determine the cost-effectiveness of interventions that increase biomedical HIV prevention uptake among adults at high-risk for HIV who attend drinking venues. The proposed research will address the critical intersection of alcohol use and HIV risk in SSA, by promoting reach and uptake of biomedical HIV prevention and exploring associated facilitators and barriers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS
Keywords
Drinking venues, Biomedical HIV prevention, Uganda, Kenya

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Aim 1: HIV-focused mobilization
Arm Type
Active Comparator
Arm Description
Patrons and workers at drinking venues will be given a recruitment card for free HIV testing at the local clinic.
Arm Title
Aim 1: Multi-disease-focused mobilization
Arm Type
Experimental
Arm Description
Patrons and workers at drinking venues will be given a recruitment card for free multi-disease testing at the local clinic, including: diabetes, hypertension, HIV, malaria, TB, pregnancy.
Intervention Type
Behavioral
Intervention Name(s)
HIV-focused mobilization
Intervention Description
Patrons and employees of drinking venues that are randomized to HIV-focused recruitment will receive a recruitment card offering free HIV testing at the local clinic
Intervention Type
Behavioral
Intervention Name(s)
Multi-disease-focused mobilization
Intervention Description
Patrons and employees of drinking venues that are randomized to HIV-focused recruitment will receive a recruitment card offering free health screenings that may include hypertension, diabetes, HIV, malaria (if febrile), and TB (if symptomatic), and pregnancy at the local clinic
Primary Outcome Measure Information:
Title
Biomedical HIV prevention uptake at 4 weeks
Description
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.
Time Frame
Measured 4 weeks after clinic screening visit
Secondary Outcome Measure Information:
Title
Biomedical HIV prevention uptake at 8 weeks
Description
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.
Time Frame
Measured 8 weeks after clinic screening visit
Title
Biomedical HIV prevention uptake at 12 weeks
Description
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who initiate PrEP or PEP after mobilization. This outcome will be measured by pill dispensing records and Ministry of Health (MoH) PrEP and PEP registry records.
Time Frame
Measured 12 weeks after clinic screening visit
Title
HIV testing uptake
Description
The proportion of HIV-negative adults, receiving an Aim 1 recruitment card, who accept clinic-based HIV testing at the clinic screening visit. HIV testing will be done in accordance with Kenyan and Ugandan national testing algorithms. Uptake will be recorded on study CRFs.
Time Frame
Measured at clinic screening visit
Title
Yield of adults with untreated HIV
Description
The proportion of persons accepting HIV testing who are identified with newly diagnosed HIV or those who are self-reported to have known HIV infection but out of care and off of ART. HIV testing will be done in accordance with Kenyan and Ugandan national testing algorithms. Uptake, test results, HIV status, and current ART use will be recorded on study CRFs.
Time Frame
Measured at clinic screening visit
Title
Yield of adults with heavy alcohol use
Description
Heavy alcohol use is defined as self-reported AUDIT-C score (a standardized, three question survey) of greater than or equal to 4 for men and greater than or equal to 3 for women. These outcomes will be recorded on study CRFs.
Time Frame
Measured at clinic screening visit
Title
Adults with untreated HIV who initiate ART
Description
The proportion of adults with untreated HIV that initiate ART. Current and prior ART use will be self-reported and recoded on study CRFs. New ART prescriptions will be measured through pill dispensing data and MoH registries.
Time Frame
Measured within one week of presenting for clinic-based screening with a recruitment card

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Participant Inclusion Criteria: adult (≥18 years) patron or worker at a drinking venue within the study community Exclusion Criteria: age <18 years previous participation in the study (may only participate once) inability to consent (including gross inebriation)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kara Marson, MPH
Phone
650-346-5774
Email
kara.marson@ucsf.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gabriel Chamie, MD, MPH
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kenya Medical Research Institute (KEMRI)
City
Mbita
Country
Kenya
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jaqui Mwango
Email
jabermwango@gmail.com
First Name & Middle Initial & Last Name & Degree
James Ayieko, MBChB, MPH, PhD
Facility Name
Infectious Diseases Research Collaboration (IDRC)
City
Mbarara
Country
Uganda
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brian Beesiga, MBChB
Phone
+256 (0) 312 281 479
Email
bbeesiga@idrc-uganda.org
First Name & Middle Initial & Last Name & Degree
Moses R Kamya, MBChB, MMed, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Per our Data Sharing agreement with the NIAAA Data Archive, we will share de-identified IPD from our baseline questionnaire, which includes questions about subject demographics, HIV risk, and alcohol use.
IPD Sharing Time Frame
Data requests can be submitted starting 3 months after article publication and the data will be made accessible for up to 36 months. Extensions will be considered on a case-by-case basis.
IPD Sharing Access Criteria
Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP).

Learn more about this trial

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

We'll reach out to this number within 24 hrs